Measurement of urine salbutamol to monitor the compliance of asthmatics
Horn, C.R.; Essex, E.; Cochrane, G.M.
Thorax 40(9): 705
1985
ISSN/ISBN: 0040-6376 Accession: 028680220
PDF emailed within 1 workday: $29.90
Related References
Safirstein, B.H.; Dhakhwa, R.B.; Gelb, B.; Fontunato, F.D. 1979: Bronchodilator effects of oral salbutamol and theophylline-salbutamol combinations in chronic steroid-dependent asthmatics Journal of the Medical Society of new Jersey 76(13): 892-894Ruffin, R.E.; Latimer, K.M.; Crockett, A.J.; Blight, M. 1988: Comparative bronchodilator study of salbutamol and salbutamol sulfate in asthmatics Australian and New Zealand Journal of Medicine 18(3 Suppl 2): 539
Hamid, S.; Kumaradevan, J.; Cochrane, G.M. 1998: Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MDI compliance monitor Respiratory Medicine 92(10): 1188-1190
Atkinson, J.A.; Frith, P.A. 1987: Repeatability of histamine and salbutamol responsiveness in asthmatics and non asthmatics Australian and New Zealand Journal of Medicine 17(4 Suppl 2): 518
Hollender, E.S.; Ashkin, D.; Narita, M. 2003: Urine color test to monitor isoniazid compliance: "pissin' in the wind"? Chest 123(3): 668-670
Eidlitz-Markus, T; Zeharia, A; Baum, G; Mimouni, M; Amir, J 2003: Use of the Urine Color Test to Monitor Compliance With Isoniazid Treatment of Latent Tuberculosis Infectiona Chest Journal 123(3): 736-739
Eidlitz-Markus, T.; Zeharia, A.; Baum, G.; Mimouni, M.; Amir, J. 2003: Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection Chest 123(3): 736-739
Vance, G.H.S.; Kilburn, S.A.; Pinder, C.; Haliday, S.; Warner, J.O. 1999: Can measurement of egg-specific Ig G be used to monitor compliance to an egg-free diet? Journal of Allergy and Clinical Immunology 103(1 Part 2): S100
Fischer, B.; Lehrl, S.; Schnaiter, A.; Schulz, H.U.; Salinger, W.; Fischer, U.; Weber, E. 1983: Compliance testing by measurement of piracetam in urine--a possible method of compliance control for piracetam intakers. An empirical investigation Neuropsychobiology 10(1): 19-22
Mareck, U.; Guddat, S.; Schwenke, A.; Beuck, S.; Geyer, H.; Flenker, U.; Elers, J.; Backer, V.; Thevis, M.; Schänzer, W. 2011: Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry Drug Testing and Analysis 3(11-12): 820-827
Sidler-Moix, A.-L.; Mercier, T.; Decosterd, L.A.; Di Paolo, E.R.; Berger-Gryllaki, M.; Cotting, J.; Pannatier, A.é 2012: A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers Biomedical Chromatography: Bmc 26(5): 672-680
Haase, C.B.; Backer, V.; Kalsen, A.; Rzeppa, S.; Hemmersbach, P.; Hostrup, M. 2016: The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis Drug Testing and Analysis 8(7): 613-620
Midgren, B.; Melander, B.; Persson, G. 1990: Formoterol vs salbutamol bid in stable asthmatics Chest 98(2 Suppl): 26S
Schumann, A.; Herxheimer, H. 1971: The bronchodilator action of salbutamol in asthmatics Postgraduate Medical Journal 47: Suppl:92-9
Ingram, J.; Gaddie, J.; Skinner, C.; Palmer, K.N. 1975: The effect of intramuscular salbutamol in asthmatics British Journal of Clinical Pharmacology 2(3): 263-266